Advanced Chemical Industries PLC. announcements
379 Dhaka Stock Exchange announcements for Advanced Chemical Industries PLC. (ACI) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (41).
- Buy Declaration of a Director
Ms. Shusmita Anis, a Director of the Company, has expressed her intention to buy 1,60,000 shares of the Company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within next 30 working days.
- Buy Confirmation of Chairman
Mr. M. Anis Ud Dowla, Chairman of the company, has further informed that he has completed his buying of 360,000 shares of the company at the prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 27.11.2025.
- Buy Declaration of Chairman
Mr. M. Anis Ud Dowla, Chairman of the company, has expressed his intention to buy 360,000 shares of the company at the prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within next 30 (thirty) working days pursuant to Regulation 34(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, as well as Rule 4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.
- Resumption after Record Date
Trading of the shares of the company will resume on 20.11.2025.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 19.11.2025.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 17.11.2025 to 18.11.2025 and trading of the shares will remain suspended on record date i.e., 19.11.2025.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 0.39 for July-September 2025 as against Tk. (4.82) for July-September 2024. Consolidated NOCFPS was Tk. (40.69) for July-September 2025 as against Tk. (54.00) for July-September 2024. Consolidated NAV per share was Tk. 93.24 as on September 30, 2025 and Tk. 91.64 as on June 30, 2025. Reasons for significant deviations: During the 1st quarter ended on 30 September 2025, (cont.1) (Cont. News of ACI): Overall, the consolidated EPS was Taka 0.39 during the period against Taka (4.82) of SPLY. NOCFPS during the period was Taka (40.69) against Taka (54.00) as a result of the movement in the working capital. (end) (Cont. News of ACI): the Group achieved a 24.40% revenue growth which was contributed by a number of businesses as demonstrated in Consolidated Operating Segments. During the period, increase in gross profit exceeded the increase in operating expenses driven by growth in key segments. On the other hand, cost of borrowing increased due to the increase of interest rate along with the additional funding for working capital and strategic investments for supporting business growth. (cont.2)
- Buy Confirmation of Chairman
M. Anis Ud Dowla, Chairman of the Company, has further informed that he has completed his buying of 5,00,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 30.10.2025.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2025 at 4:00 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
- Buy Declaration of Chairman
Mr. M. Anis Ud Dowla, Chairman of the company, has expressed his intention to buy 500,000 shares of the company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within next 30 (thirty) working days as per Rule-4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.
- Dividend Declaration (Additional Information)
Refer to the earlier news disseminated by DSE on 29.10.2025 regarding dividend declaration, the company has further informed that the recommended 25% Cash Dividend is from its retained earnings for the year ended June 30, 2025. The declared dividend has not been recommended from capital reserve or revaluation reserve or any unrealized gain of the Company or through reducing the paid-up capital.
- Dividend Declaration
The Board of Directors has recommended 25% Cash Dividend for the year ended June 30, 2025. Date of AGM: 28.12.2025, Time: 11:30 AM, Venue: Digital System. Record Date: 19.11.2025. The Company has also reported Consolidated EPS of Tk. (7.40), Consolidated NAV per share of Tk. 91.64 and Consolidated NOCFPS of Tk. (51.63) for the year ended June 30, 2025 as against Consolidated EPS of Tk. (15.88), Consolidated NAV per share of Tk. 79.31 and Consolidated NOCFPS of Tk. 0.71 (cont.1) (cont. news of ACI): On the other hand, cost of borrowings increased due to the increase of the interest rate along with additional funding for working capital and strategic investments for supporting business growth. Overall, the consolidated EPS was Taka (7.40) during the period against Taka (15.88) of SPLY. NOCFPS during the period was Taka (51.63) against Taka 0.71 mainly as a result of the investment in working capital. (end) (cont. news of ACI): for the year ended June 30, 2024. Reasons for significant deviation: During the year, the Company achieved a 10.93% growth in consolidated revenue and a 15.42% increase in consolidated gross profit. The growth in gross profit exceeded the growth in operating expenses due to cost control initiatives which contributed to the improvement of the operating profit. (cont.2)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.10.2025) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2025 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
- Board approval for formation of a new subsidiary company
The company has informed that the Board of Directors of the Company at its 224th Board meeting held on 28 July 2025 approved the formation of a new subsidiary company under the name of "ACI Biosciences Limited" having an authorized capital of BDT 100 (One Hundred) Crore and a paid up capital of BDT 25 (Twenty Five) Crore wherein Advanced Chemical Industries PLC shall hold 90% shares, at the earliest convenience, subject to the approval of the concerned authority.
- Name Change of the Company
Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'Advanced Chemical Industries PLC' instead of 'Advanced Chemical Industries Limited' with effect from June 26, 2025. Other information (except name) will remain unchanged.
- Resumption after Record Date
Trading of the shares of the company will resume on 18.06.2025 with Adjusted Open Price following the record date for effecting the amalgamation scheme.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 17.06.2025 for amalgamation purpose.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transactions will also be settled as per spot settlement cycle with cum benefit from 15.06.2025 to 16.06.2025, and trading of the shares will remain suspended on record date i.e., 17.06.2025 for issuance and allotment of 195,374 shares.
- Fixation of Record Date for issuance and allotment of 195,374 shares
Referring to their earlier news disseminated by DSE on 08.05.2025, the company has further informed that following the Judgement passed in the Company Matter No. 272 of 2022 on November 07, 2023 by the Honorable High Court Division, 195,374 nos. of ordinary shares of Tk. 10/- (Taka Ten) each only will be issued and allotted in favour of the equity shareholders of Premiaflex Plastics Limited. (cont.) (Cont. news of ACI): Name of the Shareholders and Quantity of Ordinary Shares are as follows: 1. Mr. M Anis Ud Dowla - 194,989 shares, 2. Dr. Arif Dowla - 195 shares and 3. Ms. Shusmita Anis - 190 shares. For such issue and allotment, the Record Date will be June 17, 2025. No of outstanding Shares of ACI Ltd.: Before Amalgamation: 87,636,469 shares and After Amalgamation: 87,831,843 shares (end)
- BSEC's consent on the issue and allotment of 195,374 ordinary shares
Refer to their earlier news disseminated by DSE on 19.11.2024 regarding issuing of Shares and Raising Authorized Capital. In this respect, the Bangladesh Securities and Exchange Commission has accorded its consent for raising of paid-up capital by Advanced Chemical Industries Ltd by issuing 1,95,374 nos of ordinary shares @ Tk. 10/- each only in favor of the equity shareholders of Premiaflex Plastics Ltd (cont.) (Cont. news of ACI): as per the Scheme of amalgamation approved by the shareholders and the Honorable High Court Division of the Supreme Court of Bangladesh, pursuant to Court Order in Company Matter No. 272 of 2022. (end)
- Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. (1.12) for January-March 2025 as against Tk. 0.13 for January-March 2024; Consolidated EPS was Tk. (9.11) for July 2024-March 2025 as against Tk. (7.18) for July 2023-March 2024. Consolidated NOCFPS was Tk. (83.11) for July 2024-March 2025 as against Tk. (51.03) for July 2023-March 2024. Consolidated NAV per share was Tk. 67.10 as on March 31, 2025 and Tk. 79.28 as on June 30, 2024.
- Buy Confirmation of Managing Director
Dr. Arif Dowla, Managing Director of the company, has further informed that he has completed his buying of 1,400,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated by DSE on 17.04.2025
- Buy Confirmation of a Director
Ms. Shusmita Anis, one of the Directors of the Company, has further informed that she has completed her buying of 775,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 13.04.2025.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2025 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
- Buy Declaration of Managing Director
Dr. Arif Dowla, Managing Director of the company, has expressed his intention to buy 1,400,000 shares of the company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within April 30, 2025 as per Rule-4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.
- Buy Declaration of a Director
Ms. Shusmita Anis, a Director of the Company, has expressed her intention to buy 775,000 shares of the Company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within April 30, 2025.
- Buy confirmation of Managing Director
Dr. Arif Dowla, Managing Director of the Company, has completed buying of 2,500,000 shares of the company through Dhaka Stock Exchange PLC. as per declaration disseminated on 10.02.2025.
- Buy Declaration of Managing Director
Dr. Arif Dowla, Managing Director of the Company, has expressed his intention to buy 2,500,000 shares of the Company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within next 30 working days.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. (3.17) for October-December 2024 as against Tk. (5.51) for October-December 2023; Consolidated EPS was Tk. (7.99) for July-December 2024 as against Tk. (7.30) for July-December 2023. Consolidated NOCFPS was Tk. (63.58) for July-December 2024 as against Tk. (77.05) for July-December 2023. Consolidated NAV per share was Tk. 68.33 as on December 31, 2024 and Tk. 79.28 as on June 30, 2024.
- Regarding Board approval of formation of a new subsidiary company
The company has informed that the Board of Directors of the Company in its meeting held on January 30, 2025 has approved the formation of a new subsidiary company under the title of "ACI Herbal and Nutraceuticals Limited" having an authorized capital of BDT 100 (One Hundred) Crore and a paid up capital of BDT 10 (Ten) Crore wherein Advanced Chemical Industries PLC shall hold 85% shares at the earliest convenience subject to the approval of the concerned authority.
- Buy Confirmation of Chairman
M. Anis Ud Dowla, Chairman of the Company, has further informed that he has completed his buying of 16,00,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 26.01.2025.
- Buy Declaration of Chairman
Mr. M. Anis Ud Dowla, Chairman of the company, has expressed his intention to buy 1,600,000 shares of the company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within next 30 (thirty) working days as per Rule 4 of the BSEC (Substantial Acquisition of Shares Rules, 2018).
- Buy confirmation of Nominated Director
Ms. Shusmita Anis, a Nominated Director of the Company, has further informed that she has completed her buying of 1,515,000 shares of the Company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 15.01.2025.
- Dividend Disbursement
The Company has informed that it has credited the Bonus Shares for the year ended June 30, 2024 to the respective shareholders' BO Accounts.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2025 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
- Buy confirmation of Managing Director
Dr. Arif Dowla, Managing Director of the Company, has further informed that he has completed his buying of 6,00,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 09.01.2025.
- Buy Declaration of a Director
Ms. Shusmita Anis, a Director of the Company, has expressed her intention to buy 1,515,000 shares of the Company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within next 30 working days.
- Buy Declaration of Managing Director
Dr. Arif Dowla, Managing Director of the Company, has expressed his intention to buy 6,00,000 shares of the Company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC. within next within next 30 working days.
- Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has assigned the rating of the Company as "AA-" in the long term and "ST-2" in the short term along with Stable outlook in consideration of its audited financials up to June 30, 2024 also unaudited financials up to September 30, 2024 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.